- Report
- February 2024
- 90 Pages
Asia Pacific
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 80 Pages
Europe
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 117 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 112 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 110 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 113 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 110 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 112 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- August 2022
- 115 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- August 2022
- 96 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- August 2024
- 150 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- July 2024
- 150 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- March 2026
- 200 Pages
Japan
From €2505EUR$2,789USD£2,140GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3475EUR$3,869USD£2,968GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3475EUR$3,869USD£2,968GBP
- Report
- July 2025
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- July 2025
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3475EUR$3,869USD£2,968GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more